Device Trial Radar · NCT06066645
Travoprost Intraocular Implant + iStent Infinite
Last checked: Nov 19, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Sep 14, 2023
Primary completion
May 2027
Study completion Feb 2028
Sponsor
- Lead sponsor
- Glaukos CorporationPublic (GKOS)
- Sponsor type
- Industry
- First posted
- Oct 4, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Conditions
- Glaucoma, Open-Angle
Interventions
Travoprost Intraocular ImplantDrug
anchored intracameral implant containing travoprost
iStent infiniteDevice
Successful iStent infinite surgery
Sham procedureOther
Sham procedure (to mimic placement of an iStent infinite)
Primary outcomes
What the sponsor says the trial is designed to measure.
- change from baseline in mean diurnal intraocular pressure (IOP)Time frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Glaukos Clinical Study Site
Oklahoma City, Oklahoma · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.